1. Home
  2. ENFY vs RLMD Comparison

ENFY vs RLMD Comparison

Compare ENFY & RLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENFY
  • RLMD
  • Stock Information
  • Founded
  • ENFY 1987
  • RLMD 2004
  • Country
  • ENFY China
  • RLMD United States
  • Employees
  • ENFY 424
  • RLMD N/A
  • Industry
  • ENFY
  • RLMD Biotechnology: Pharmaceutical Preparations
  • Sector
  • ENFY
  • RLMD Health Care
  • Exchange
  • ENFY NYSE
  • RLMD Nasdaq
  • Market Cap
  • ENFY 11.8M
  • RLMD 11.5M
  • IPO Year
  • ENFY N/A
  • RLMD N/A
  • Fundamental
  • Price
  • ENFY $0.80
  • RLMD $0.37
  • Analyst Decision
  • ENFY
  • RLMD Hold
  • Analyst Count
  • ENFY 0
  • RLMD 4
  • Target Price
  • ENFY N/A
  • RLMD $4.25
  • AVG Volume (30 Days)
  • ENFY 50.0K
  • RLMD 942.1K
  • Earning Date
  • ENFY 02-07-2025
  • RLMD 03-18-2025
  • Dividend Yield
  • ENFY N/A
  • RLMD N/A
  • EPS Growth
  • ENFY N/A
  • RLMD N/A
  • EPS
  • ENFY N/A
  • RLMD N/A
  • Revenue
  • ENFY $90,812,865.00
  • RLMD N/A
  • Revenue This Year
  • ENFY N/A
  • RLMD N/A
  • Revenue Next Year
  • ENFY N/A
  • RLMD N/A
  • P/E Ratio
  • ENFY N/A
  • RLMD N/A
  • Revenue Growth
  • ENFY N/A
  • RLMD N/A
  • 52 Week Low
  • ENFY $0.75
  • RLMD $0.34
  • 52 Week High
  • ENFY $3.32
  • RLMD $7.22
  • Technical
  • Relative Strength Index (RSI)
  • ENFY N/A
  • RLMD 25.62
  • Support Level
  • ENFY N/A
  • RLMD $0.36
  • Resistance Level
  • ENFY N/A
  • RLMD $0.49
  • Average True Range (ATR)
  • ENFY 0.00
  • RLMD 0.06
  • MACD
  • ENFY 0.00
  • RLMD 0.08
  • Stochastic Oscillator
  • ENFY 0.00
  • RLMD 10.06

About ENFY ENLIGHTIFY INC

Enlightify Inc Formerly China Green Agriculture Inc is engaged in the business of fertilizer and agricultural products. It involves the research, development, production, distribution, and sale of humic acid-based compound fertilizers, blended fertilizers, organic compound fertilizers, slow-release fertilizers, concentrated water-soluble fertilizers, and mixed organic-inorganic compound fertilizers and the development, production, and distribution of agricultural products, such as top-grade fruits, vegetables, flowers and colored seedlings in China. The company operates in four segments: Jinong (fertilizer production), Gufeng (fertilizer production), Yuxing (agricultural products production), and Antaeus (Bitcoin). All of its operations are conducted in China.

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

Share on Social Networks: